Structural mapping of Nav1.7 antagonists

Nat Commun. 2023 Jun 3;14(1):3224. doi: 10.1038/s41467-023-38942-3.

Abstract

Voltage-gated sodium (Nav) channels are targeted by a number of widely used and investigational drugs for the treatment of epilepsy, arrhythmia, pain, and other disorders. Despite recent advances in structural elucidation of Nav channels, the binding mode of most Nav-targeting drugs remains unknown. Here we report high-resolution cryo-EM structures of human Nav1.7 treated with drugs and lead compounds with representative chemical backbones at resolutions of 2.6-3.2 Å. A binding site beneath the intracellular gate (site BIG) accommodates carbamazepine, bupivacaine, and lacosamide. Unexpectedly, a second molecule of lacosamide plugs into the selectivity filter from the central cavity. Fenestrations are popular sites for various state-dependent drugs. We show that vinpocetine, a synthetic derivative of a vinca alkaloid, and hardwickiic acid, a natural product with antinociceptive effect, bind to the III-IV fenestration, while vixotrigine, an analgesic candidate, penetrates the IV-I fenestration of the pore domain. Our results permit building a 3D structural map for known drug-binding sites on Nav channels summarized from the present and previous structures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / pharmacology
  • Carbamazepine*
  • Humans
  • Lacosamide
  • Pain
  • Protein Domains
  • Voltage-Gated Sodium Channel Blockers* / chemistry
  • Voltage-Gated Sodium Channels / metabolism

Substances

  • Analgesics
  • Carbamazepine
  • Lacosamide
  • Voltage-Gated Sodium Channels
  • Voltage-Gated Sodium Channel Blockers